Recent genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with risk of esophageal cancer (EC). However, investigation of genetic basis from the perspective of systematic biology and integrative genomics remains scarce.</p
Esophageal adenocarcinoma (EA) is an often fatal cancer with rising incidence in the developed world...
We conducted a joint (pooled) analysis of three genome-wide association studies (GWAS)(1-3) of esoph...
Genome-wide association studies (GWAS) provide an agnostic approach for investigating the genetic ba...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
Background Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barre...
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
Several cancer-associated loci identified from genome-wide association studies (GWAS) have been asso...
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
BACKGROUND & AIMS: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Esophageal adenocarcinoma (EA) is an often fatal cancer with rising incidence in the developed world...
Several cancer-associated loci identified from genome-wide association studies (GWAS) have been asso...
Esophageal adenocarcinoma (EA) is an often fatal cancer with rising incidence in the developed world...
We conducted a joint (pooled) analysis of three genome-wide association studies (GWAS)(1-3) of esoph...
Genome-wide association studies (GWAS) provide an agnostic approach for investigating the genetic ba...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
The development of new high-throughput genotyping technologies has allowed fast evaluation of single...
Background Esophageal adenocarcinoma (EA) is an increasingly common cancer with poor survival. Barre...
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Background Esophageal adenocarcinoma (EA) is one of the fastest rising cancers in western countries....
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
Several cancer-associated loci identified from genome-wide association studies (GWAS) have been asso...
Objective Oesophageal cancer (EC) is the sixth leading cause of cancer-related deaths. Oesophageal a...
BACKGROUND & AIMS: Genome-wide association studies (GWAS) have identified more than 20 susceptibilit...
Esophageal adenocarcinoma (EA) is an often fatal cancer with rising incidence in the developed world...
Several cancer-associated loci identified from genome-wide association studies (GWAS) have been asso...
Esophageal adenocarcinoma (EA) is an often fatal cancer with rising incidence in the developed world...
We conducted a joint (pooled) analysis of three genome-wide association studies (GWAS)(1-3) of esoph...
Genome-wide association studies (GWAS) provide an agnostic approach for investigating the genetic ba...